Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,782.81
(
2.51%
)
US TECH 100
24,183.06
(
2.72%
)
Dow Jones
47,909.92
(
2.85%
)
Brent Oil
95.34
(
0.53%
)
Bitcoin
70,982.97
(
-0.21%
)
News Focus
News Focus
Post# of 820823
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

antihama

Send PM Follow Ignore
Followers 56
Posts 3712
Boards Moderated 0
Alias Born 10/26/2013

antihama

Re: meirluc post# 500190

Tuesday, 08/02/2022 5:46:34 PM

Tuesday, August 02, 2022 5:46:34 PM

Post# of 820823
That's good food for thought meirluc but wouldn't it be more advantageous for NWBO/Statistical Significance if they used all of the ITT placebo group including, as you point out, the 33 that are probably sicker than the 64 who crossed over? So I don't think they are trying to pull the wool over the Journal's eyes. And the External Controls were pre-specified in the SAP which I assume was discussed with the Regulatory Authorities.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News